Dan Sheridan Talks Covid Vaccine Stocks
Dan Sheridan on Johnson & Johnson (JNJ) saying that a single-dose Covid-19 vaccine is 66% effective in moderate-to-severe cases. Also, Eli Lilly (LLY) reported earnings of $2.75 EPS with a $7.44B in revenue.
MID-DAY Movers
29 Jan 2021
Related videos
05:07
George Seay On The Benefits Of An RIA For Your Investing Path
Market Overtime
27 Jan 2021
06:29
Sel Hardy On What To Watch In The Health Care Sector
The Watch List
16 Nov 2020
04:28
Ted Oakley Talks Healthcare Sector
The Watch List
30 Nov 2020
07:54
Brad Loncar On Areas Of Opportunity In The Healthcare Sector
Market Overtime
29 Jan 2021
04:25
Example Trades Of The Week: BA, JNJ, MCD, MDLZ
Your First Trade
04 Feb 2021
ON AIR
7:00 amFutures
Dan Sheridan Talks Covid Vaccine Stocks
Dan Sheridan on Johnson & Johnson (JNJ) saying that a single-dose Covid-19 vaccine is 66% effective in moderate-to-severe cases. Also, Eli Lilly (LLY) reported earnings of $2.75 EPS with a $7.44B in revenue.
MID-DAY Movers
29 Jan 2021
Related videos
George Seay On The Benefits Of An RIA For Your Investing Path
Market Overtime
27 Jan 202105:07
Sel Hardy On What To Watch In The Health Care Sector
The Watch List
16 Nov 202006:29
Ted Oakley Talks Healthcare Sector
The Watch List
30 Nov 202004:28
Brad Loncar On Areas Of Opportunity In The Healthcare Sector
Market Overtime
29 Jan 202107:54
Example Trades Of The Week: BA, JNJ, MCD, MDLZ
Your First Trade
04 Feb 202104:25